{"log_id": 5236976800370877582, "direction": 0, "words_result_num": 42, "words_result": [{"probability": {"variance": 0, "average": 0.999584, "min": 0.997849}, "location": {"width": 455, "top": 169, "height": 42, "left": 149}, "words": "小鼠腹腔内注入细菌,未发现细菌的突变率升高"}, {"probability": {"variance": 9.8e-05, "average": 0.991884, "min": 0.974897}, "location": {"width": 89, "top": 210, "height": 25, "left": 148}, "words": "他唑巴坦"}, {"probability": {"variance": 0.002281, "average": 0.979064, "min": 0.748021}, "location": {"width": 947, "top": 244, "height": 64, "left": 190}, "words": "他唑巴坦在微生物致突变实验中浓度高达3g平板时结果为阴性。他唑巴坦在UDS实验中浓度高达"}, {"probability": {"variance": 0.013861, "average": 0.940517, "min": 0.423887}, "location": {"width": 988, "top": 285, "height": 65, "left": 149}, "words": "20g/ml时结果为阴性。他唑巴坦在哺乳动物点突变实验(中国仓鼠卵巢细胞HPRT)中浓度高达5000gml"}, {"probability": {"variance": 0.00052, "average": 0.990858, "min": 0.897082}, "location": {"width": 994, "top": 321, "height": 63, "left": 141}, "words": "时结果为阴性。另一项哺乳动物点突变实验(小鼠淋巴瘤细胞)中,他唑巴坦浓度≥3000g/ml时结果为阴"}, {"probability": {"variance": 0.00724, "average": 0.971882, "min": 0.449326}, "location": {"width": 993, "top": 357, "height": 64, "left": 141}, "words": "性。他唑巴坦在细胞(BALB/c-3T3)转化实验中浓度高达900g/ml时结果为阴性。另一项体外细胞遗传"}, {"probability": {"variance": 0.002028, "average": 0.984032, "min": 0.725852}, "location": {"width": 993, "top": 395, "height": 64, "left": 140}, "words": "学实验(中国仓鼠肺细胞)中,他唑巴坦浓度高达300g/ml时结果为阴性。体内实验中,他唑巴坦静脉"}, {"probability": {"variance": 0.004177, "average": 0.985862, "min": 0.541273}, "location": {"width": 994, "top": 434, "height": 62, "left": 137}, "words": "给药剂量达到5000mg/kg时不诱导大鼠的染色体畸变,该剂量相当于按体表面积计算人用每日最大推荐剂"}, {"probability": {"variance": 0.00044, "average": 0.98807, "min": 0.937791}, "location": {"width": 199, "top": 473, "height": 31, "left": 137}, "words": "量(mg/m2)的23倍"}, {"probability": {"variance": 1e-06, "average": 0.998291, "min": 0.9967}, "location": {"width": 138, "top": 512, "height": 27, "left": 143}, "words": "【药代动力学】"}, {"probability": {"variance": 0, "average": 0.999289, "min": 0.998965}, "location": {"width": 45, "top": 550, "height": 27, "left": 135}, "words": "成人"}, {"probability": {"variance": 0.042866, "average": 0.800539, "min": 0.41526}, "location": {"width": 246, "top": 527, "height": 37, "left": 724}, "words": "受理号C(HBc5(8"}, {"probability": {"variance": 0, "average": 0.886435, "min": 0.886435}, "location": {"width": 21, "top": 550, "height": 22, "left": 1093}, "words": "粤"}, {"probability": {"variance": 0.006807, "average": 0.967866, "min": 0.597873}, "location": {"width": 950, "top": 582, "height": 69, "left": 172}, "words": "本品静脉滴注结束后哌拉西林和他唑巴坦迅速达血浆峰浓。本品滴注结分拉达血浆"}, {"probability": {"variance": 0.022508, "average": 0.929331, "min": 0.407597}, "location": {"width": 977, "top": 613, "height": 86, "left": 130}, "words": "峰浓度,与单独使用相同剂量的哌拉西林的血浆峰浓度相似到番费药"}, {"probability": {"variance": 0.003811, "average": 0.974092, "min": 0.745057}, "location": {"width": 615, "top": 662, "height": 51, "left": 127}, "words": "药后的哌拉西林平均血浆峰浓度分别约为134和298μg/ml。他唑"}, {"probability": {"variance": 0.019143, "average": 0.771952, "min": 0.664354}, "location": {"width": 77, "top": 706, "height": 25, "left": 131}, "words": " 34ug/mlo"}, {"probability": {"variance": 0.000746, "average": 0.991784, "min": 0.858101}, "location": {"width": 954, "top": 738, "height": 62, "left": 166}, "words": "本品2.25g或4.5g每6小时1次,每次30分钟静脉滴注后的哌拉西林和他唑巴坦稳态血浆浓度与首剂"}, {"probability": {"variance": 3.3e-05, "average": 0.998399, "min": 0.962245}, "location": {"width": 907, "top": 776, "height": 55, "left": 126}, "words": "用药后的浓度没有差别。本品每6小时1次、每次30分钟静脉滴注后的稳态血浆浓度数据见表3"}, {"probability": {"variance": 0.002329, "average": 0.987851, "min": 0.682055}, "location": {"width": 949, "top": 815, "height": 57, "left": 165}, "words": "健康受试者单剂或多剂使用本品后,哌拉西林和他唑巴坦的血浆半衰期范围为0.7—12小时,不受剂"}, {"probability": {"variance": 3e-06, "average": 0.998426, "min": 0.994786}, "location": {"width": 237, "top": 853, "height": 32, "left": 121}, "words": "量和静脉滴注时间的影响"}, {"probability": {"variance": 1.6e-05, "average": 0.998036, "min": 0.976937}, "location": {"width": 952, "top": 889, "height": 58, "left": 161}, "words": "哌拉西林被代谢为有微弱微生物学活性的去乙基代谢产物,他唑巴坦则被代谢为一种没有药理学活性"}, {"probability": {"variance": 1.7e-05, "average": 0.997606, "min": 0.978361}, "location": {"width": 991, "top": 926, "height": 59, "left": 117}, "words": "和抗菌活性的代谢产物。哌拉西林和他唑巴坦均通过肾小球滤过和肾小管分泌,经肾脏排泄。哌拉西林给"}, {"probability": {"variance": 0.000107, "average": 0.997178, "min": 0.928758}, "location": {"width": 991, "top": 965, "height": 57, "left": 116}, "words": "药剂量的68%以原形药通过尿液快速排出。他唑巴坦及其代谢物主要经肾脏清除,其中给药剂量的80%以"}, {"probability": {"variance": 6e-05, "average": 0.996569, "min": 0.95768}, "location": {"width": 923, "top": 1002, "height": 55, "left": 114}, "words": "原形药物排出,其余部分为单一的代谢产物。哌拉西林、他唑巴坦和去乙基哌拉西林亦从胆汁排泄"}, {"probability": {"variance": 1.5e-05, "average": 0.997349, "min": 0.979757}, "location": {"width": 950, "top": 1041, "height": 56, "left": 155}, "words": "哌拉西林和他唑巴坦约30%与血浆蛋白结合,哌拉西林和他唑巴坦的蛋白结合率均不受其他化合物的"}, {"probability": {"variance": 8e-06, "average": 0.998474, "min": 0.986959}, "location": {"width": 497, "top": 1079, "height": 40, "left": 110}, "words": "影响,他唑巴坦代谢产物的蛋白结合率可以忽略不计"}, {"probability": {"variance": 1.7e-05, "average": 0.997767, "min": 0.979293}, "location": {"width": 950, "top": 1117, "height": 54, "left": 151}, "words": "哌拉西林和他唑巴坦在肠粘膜、胆囊、肺、女性生殖器官(子宫、卵巢和输卵管)、组织间液和胆汁等"}, {"probability": {"variance": 0.001063, "average": 0.987872, "min": 0.847586}, "location": {"width": 993, "top": 1153, "height": 56, "left": 106}, "words": "组织和体液中的分布广泛,平均组织浓度一般为血浆浓度的50%100%哌拉西林和他唑巴坦与其他青霉素"}, {"probability": {"variance": 1e-06, "average": 0.999279, "min": 0.9961}, "location": {"width": 434, "top": 1193, "height": 38, "left": 105}, "words": "类一样,在脑膜无炎症者的脑脊液中分布较少"}, {"probability": {"variance": 0.062449, "average": 0.744689, "min": 0.494791}, "location": {"width": 129, "top": 1196, "height": 67, "left": 996}, "words": "联产"}, {"probability": {"variance": 0.003831, "average": 0.987694, "min": 0.57807}, "location": {"width": 1005, "top": 1230, "height": 57, "left": 146}, "words": "肾功能损害的患者单剂使用哌拉西林/他唑巴坦后,哌拉西林和他唑巴坦的半衰期随肌酐清除率的降低"}, {"probability": {"variance": 0.010038, "average": 0.967606, "min": 0.447105}, "location": {"width": 1064, "top": 1267, "height": 60, "left": 100}, "words": "而延长。肌酐清除率低于20ml/min的患者与肾功能正常者相比,哌拉西林的半衰期延长2倍,他唑巴的"}, {"probability": {"variance": 0.005432, "average": 0.985457, "min": 0.493754}, "location": {"width": 1075, "top": 1303, "height": 65, "left": 100}, "words": "半衰期延长4倍。按常规推荐剂量使用本品(注射用哌拉西林和他唑巴坦)治疗的患者在肌酐清除率低彩"}, {"probability": {"variance": 0.000511, "average": 0.993461, "min": 0.856398}, "location": {"width": 839, "top": 1346, "height": 49, "left": 103}, "words": "4m/min时,建议调整本品的剂量(见治疗肾功能不全患者的特殊建议中的【用法用量】)"}, {"probability": {"variance": 0.006477, "average": 0.97857, "min": 0.549365}, "location": {"width": 951, "top": 1384, "height": 53, "left": 140}, "words": "血液透析可以清除哌拉西林/他唑巴坦给药剂量的30%—40%,另有5%的他唑巴坦以其代谢产物的形式"}, {"probability": {"variance": 2.1e-05, "average": 0.997584, "min": 0.973089}, "location": {"width": 993, "top": 1421, "height": 53, "left": 98}, "words": "被清除。腹膜透析分别可清除哌拉西林给药剂量的约6%和他唑巴坦给药剂量的约21%,最多可有16%的他"}, {"probability": {"variance": 0.000359, "average": 0.993308, "min": 0.902061}, "location": {"width": 880, "top": 1458, "height": 50, "left": 96}, "words": "唑巴坦以其代谢产物的形式被清除。对于血液透析患者给药剂量的推荐意见详见【用法用量】。"}, {"probability": {"variance": 1.5e-05, "average": 0.997851, "min": 0.975552}, "location": {"width": 954, "top": 1497, "height": 53, "left": 134}, "words": "肝硬化患者与健康受试者相比,哌拉西林和他唑巴坦的半衰期分别延长约25%和18%,但是肝硬化患"}, {"probability": {"variance": 1.3e-05, "average": 0.997695, "min": 0.987797}, "location": {"width": 305, "top": 1535, "height": 36, "left": 92}, "words": "者并不需要因此调整本品的剂量"}, {"probability": {"variance": 2.3e-05, "average": 0.996123, "min": 0.983464}, "location": {"width": 438, "top": 1580, "height": 42, "left": 382}, "words": "表3成年人哌拉西林他唑巴坦每6小时1次"}, {"probability": {"variance": 1e-06, "average": 0.999313, "min": 0.995836}, "location": {"width": 423, "top": 1618, "height": 40, "left": 398}, "words": "每次30分钟静脉滴注后的平均稳态血浆浓度"}], "language": 3}